Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome

Pediatric Blood and Cancer

Volumn 47, Issue 3, 2006, Pages 273-278

  Frühwald, Michael C ^a   Hasselblatt, Martin ^a   Wirth, Sebastian ^a   Köhler, Gabriele ^a   Schneppenheim, Reinhard ^b   Subero, Jose Igancio Martin ^c   Siebert, Reiner ^c   Kordes, Uwe ^b   Jürgens, Heribert ^a   Vormoor, Josef ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Atypical teratoid rhabdoid tumor; Embryonal tumor; hSNF5; INI1; Rhabdoid tumor predisposition syndrome; Rhabdoid tumors; SMARCB1

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN; DOXORUBICIN; EPITHELIAL MEMBRANE ANTIGEN; ETOPOSIDE; GENE PRODUCT; HSNF5 PROTEIN; IFOSFAMIDE; INI1 PROTEIN; PROTEIN SWI; SMARCB1 PROTEIN; SMOOTH MUSCLE ACTIN; TOPOTECAN; UNCLASSIFIED DRUG; VIMENTIN; VINCRISTINE;

ARTICLE; CANCER SUSCEPTIBILITY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD DEATH; CHROMOSOME 22Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE INACTIVATION; GENE LOCUS; HAPLOTYPE; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY TUMOR; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOID TUMOR; SMARCB1 GENE; SOFT TISSUE TUMOR; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

CHROMOSOMAL PROTEINS, NON-HISTONE; CYTOGENETIC ANALYSIS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FAMILY HEALTH; FATAL OUTCOME; FEMALE; GENETIC LINKAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LINKAGE (GENETICS); MAGNETIC RESONANCE IMAGING; RHABDOID TUMOR; SENSITIVITY AND SPECIFICITY; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS;

EID: 33746642122     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20526     Document Type: Article

References (19)

1. Creutzig U, Henze G, Bielack S, et al. Krebserkrankungen bei Kindern. Erfolg durch einheitliche Therapiekonzepte seit 25 Jahren. Dtsch Ärztebl 2003;13:A842-A852.
2. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: Results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48.
3. Briner JFB, Kleihues P. Malignant small cell tumor of the brain with intermediate filaments: A case of primary cerebral rhabdoid tumor. Pediatr Pathol 1985;3:117-118.
4. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J Neurosurg 1996;85:56-65.
5. Biegel JA, Rorke LB, Emanuel BS. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. N Engl J Med 1989;321:906.
6. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-206.
7. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004;28:644-650.
8. Lynch HT, Shurin SB, Dahms BB, et al. Paravertebral malignant rhabdoid tumor in infancy. In vitro studies of a familial tumor. Cancer 1983;52:290-296.
9. Proust F, Laquerriere A, Constantin B, et al. Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neurooncol 1999;43:63-70.
10. Sevenet N, Sheridan E, Amram D, et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999;65:1342-1348.
11. Lee HY, Yoon CS, Sevenet N, et al. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome. Pediatr Dev Pathol 2002;5:395-399.
12. Gascoyne RD, Lamant L, Martin-Subero JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: Report of 6 cases. Blood 2003;102:2568-2573.
13. Ricken CH, Paulus W. Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumors. Childs Nerv Syst 2004;20:221-224.
14. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-79.
15. Sevenet N, Lellouch-Tubiana A, Schofield D, et al. Spectrum of hSNFS/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 1999;8:2359-2368.
16. Savla J, Chen TT, Schneider NR, et al. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 2000;92:648-650.
17. Taylor MD, Gokgoz N, Andrulis IL, et al. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 2000;66:1403-1406.
18. Fernandez C, Bouvier C, Sevenet N, et al. Congenital disseminated malignant rhabdoid tumor and cerebellar tumor mimicking medulloblastoma in monozygotic twins: Pathologic and molecular diagnosis. Am J Surg Pathol 2002;26:266-270.
19. Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-3467.